Dr. Elber S Camacho MD Internist

Dr. Elber Camacho is an internist in Palm Springs, California. He is affiliated with multiple hospitals in the area, including Desert Regional Medical Center and Eisenhower Medical Center. He received his medical degree from Loma Linda University School of Medicine and has been in practice for 42 years. He is one of 14 doctors at Desert Regional Medical Center and one of 47 at Eisenhower Medical Center who specialize in Internal Medicine.

Are you Dr. Elber Camacho? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Internist: General Internal Medicine

Education & Medical Training

Loma Linda University
Residency, Internal Medicine, 1973 - 1975

University of Pennsylvania Health System
Residency, Internal Medicine, 1972 - 1973

Memorial Sloan-Kettering Cancer Center
Fellowship, Immunology, 1976 - 1979

Loma Linda University School of Medicine
Class of 1972

Certifications & Licensure

American Board of Internal Medicine
Certified in Gastroenterology

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Transplant Hepatology

AZ State Medical License
Active through 2014

Publications & Presentations

Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.
Bensinger, W. I., Jagannath, S., Vescio, R., Camacho, E., Wolf, J., Irwin, D., Capo, G., McKinley, M., Potts, P., Vesole, D. H., Mazumder, A., Crowley, J., Becker, P., Hilger, J., Durie, B. G.

Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma.
Jagannath, S., Durie, B. G., Wolf, J. L., Camacho, E. S., Irwin, D., Lutzky, J., McKinley, M., Potts, P., Gabayan, A. E., Mazumder, A., Crowley, J., Vescio, R.

Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
Friedberg, J.W., Cohen, P., Chen, L., Robinson, K.S., Forero-Torres, A., La Casce, A.S., Fayad, L.E., Bessudo, A., Camacho, E.S., Williams, M.E., van der Jagt, R.H., Oliver, J.W., Cheson, B.D.

See all 6 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • Anthem KeyCare PPO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CareFirst BCBS Maryland POS
  • CareFirst BlueChoice Advantage
  • CareFirst BlueChoice Network POS
  • CareFirst BluePreferred PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Cofinity PPO
  • Coventry Carelink Health Plans PPO
  • Coventry Virginia - HMO
  • First Health PPO
  • Great West PPO
  • HealthLink PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Sagamore Health Plus
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.